Abstract:HER2 extracellular domain (HER2_ECD) protein is a potential tumor vaccine for containing more antigenic epitopes that have more potent immunogenicity than the antigenic polypeptide. Transmembrane and secretory antigens are different in receptor binding, biological effects and action mechanisms. Therefore, it is necessary to prepare two kinds of HER2_ECD protein for its potential application. In this study, pDisplay and pCMV were used as vectors for the expression of transmembrane and secretory HER2_ECD. A sequence of transmembrane region (PDGFR Transmembrane Domain) is located behind the signal peptide and the cleavage site in the pDisplay. The PCR product HER2_ECD fragment was cloned into pDisplay to form recombinant plasmid pDisplay-HER2_ECD which was then transiently transfected in HEK293T cells. The expressed protein was confirmed to be 130kDa by Western Blotting, which was in agreement with the theoretical size of HER2_ECD. The positive rate of the transient cells in the experimental group was from 51.00% to 52.08% compared with the blank control group by flow fluorescence analysis. Moreover, green fluorescence (FITC) and red fluorescence (PE) were observed on the parallel cells of the experimental group compared with the blank control group by confocal microscopy fluorescence detection, which indicated that HER2_ECD was successfully expressed on the membrane. In order to facilitate the expression, purification and test, an Fc fragment was fused with HER2_ECD by overlap PCR then cloned into pCMV to get the recombinant plasmid pCMV-HER2_ECD-Fc which was then transiently transfected in HEK293T cells. Western Blotting analysis suggested that the expressed protein collected from the supernatant was 150 kDa, which was in accordance with the theoretical size of HER2_ECDFc. Purified by protein an affinity chromatography, the purity of recombinant HER2_ECD-Fc was confirmed to be 98.10% by SDS-PAGE and HPLC. In summary, transmembrane and secretory HER2_ECD proteins were successful prepared to be homogenesis by membranedocking and secretory expression in mammalian cells.

Expression and Identification of Recombinant Human HER2/neu Extracellular Domain in Pichia Pastoris

[Expression of xenogeneic homologous epidermal growth factor receptor ectodomain in Pichia pastoris].

Cloning and Prokaryotic Expression of HER-2/neu Extracellular Domain

Expression and Characterization of Recombinant Humanized Anti-Her2 Single-Chain Antibody in Pichia Pastoris for Targeted Cancer Therapy

Expression and identification of transmembrane and secretory human HER 2 extracellular domain

Expression, Purification and Renaturation of HER-2/neu RLD Protein

Expression of tumor necrosis factor receptor-immunoglobulin G1 Fc fusion protein in glycoengineered Pichia pastoris

Expression, purification and identification of RANTES in Pichia Pastoris

Cloning and Expression of Recombinant Human Cytomegalovirus Peptide Gene in {\sl Pichia Pastoris}

Engineering of a Pichia pastoris Expression System for High-Level Secretion of HSA/GH Fusion Protein

Expression and Characterization of Recombinant Porcine Β-Defensin-2 Gene in Pichia Pastoris

[Expression and Characterization of Human Vascular Endothelial Growth Factor in Pichia Pastoris].

The Secreted Expression of HPV16-E7 in Pichia Pastoris

Pichia Expression of Human EGFR

Glycoengineered Pichia Produced Anti-Her2 is Comparable to Trastuzumab in Preclinical Study.

EXPRSSION OF HUMAN ENDOSTATIN IN PICHIA PASTORIS

Expression of Chicken NPY Gene in Pichia Pastoris

Secreted Expression of Hepatitis E Virus ORF2 Gene in Pichia pastoris and Identification of Its Biological Activity

[Expression of Quail Vascular Endothelial Growth Factor Receptor Quek-1 Extracellular Domain 2-4 Loop Cdna in Pichia Pastoris].

Expression and identification of recombinant humanuPA17-KPI in Pichia pastoris

Secretory Expression of Helicobacter Pylori Multi-Epitope Peptide in Pichia Pastoris